switching from tirzepatide to wegovy Mounjaro in 2025 Considering a Switch from Mounjaro

Conclusion: Your Path to a Healthier You Semaglutide can be a powerful tool in your weight loss journey

Clinical evidence: The SURMOUNT-1 trial, published in the New England Journal of Medicine , showed that participants on the highest dose of tirzepatide (15 mg) lost an average of 22.5 percent of their body weight over 72 weeks the most weight loss ever demonstrated by a pharmaceutical agent in a clinical trial (Jastreboff et al., 2022)

Its approved by the Food and Drug Administration (FDA) for use with diet and exercise to help manage blood sugar levels in adults and children ages 10 years and older with type 2 diabetes

Semaglutide Injections are prescription medicines, so they should be bought only with a valid prescription